Leukocyte trafficking to the small intestine and colon

A Habtezion, LP Nguyen, H Hadeiba, EC Butcher - Gastroenterology, 2016 - Elsevier
Leukocyte trafficking to the small and large intestines is tightly controlled to maintain
intestinal immune homeostasis, mediate immune responses, and regulate inflammation. A …

CC chemokine receptors and chronic inflammation—therapeutic opportunities and pharmacological challenges

GE White, AJ Iqbal, DR Greaves, CJ Garland - Pharmacological reviews, 2013 - Elsevier
Chemokines are a family of low molecular weight proteins with an essential role in leukocyte
trafficking during both homeostasis and inflammation. The CC class of chemokines consists …

[HTML][HTML] Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models

E Mizoguchi, D Low, Y Ezaki, T Okada - Intestinal research, 2020 - synapse.koreamed.org
The specific pathogenesis underlining inflammatory bowel disease (IBD) is very
complicated, and it is further more difficult to clearly explain the pathophysiology of 2 major …

Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances

S Zundler, E Becker, LL Schulze, MF Neurath - Gut, 2019 - gut.bmj.com
Intestinal immune cell trafficking has been identified as a central event in the pathogenesis
of inflammatory bowel diseases (IBD). Intensive research on different aspects of the immune …

Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease

RJ Dart, I Zlatareva, P Vantourout, E Theodoridis… - Science, 2023 - science.org
Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial
butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in …

Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise

PJ Trivedi, DH Adams - Journal of Crohn's and Colitis, 2018 - academic.oup.com
The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have
been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10 …

The roles of CCR9/CCL25 in inflammation and inflammation-associated diseases

X Wu, M Sun, Z Yang, C Lu, Q Wang… - Frontiers in cell and …, 2021 - frontiersin.org
Chemokine is a structure-related protein with a relatively small molecular weight, which can
target cells to chemotaxis and promote inflammatory response. Inflammation plays an …

[HTML][HTML] Inflammatory pathways of importance for management of inflammatory bowel disease

J Pedersen, M Coskun, C Soendergaard… - World journal of …, 2014 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is a group of chronic disorders of the gastrointestinal tract
comprising Crohn's disease (CD) and ulcerative colitis (UC). Their etiologies are unknown …

Targeting chemokine receptors in chronic inflammatory diseases: an extensive review

PJ Koelink, SA Overbeek, S Braber, P de Kruijf… - Pharmacology & …, 2012 - Elsevier
The traffic of the different types of immune cells is an important aspect in the immune
response. Chemokines are soluble peptides that are able to attract cells by interaction with …

[HTML][HTML] Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity

PJ Trivedi, T Bruns, S Ward, M Mai, C Schmidt… - Journal of …, 2016 - Elsevier
CCL25-mediated activation of CCR9 is critical for mucosal lymphocyte recruitment to the
intestine. In immune-mediated liver injury complicating inflammatory bowel disease …